Found: 9
Select item for more details and to access through your institution.
Biallelic BIRC3 inactivation in chronic lymphocytic leukaemia patients with 11q deletion identifies a subgroup with very aggressive disease.
- Published in:
- Angewandte Chemie, 2019, v. 131, n. 15, p. 156, doi. 10.1111/bjh.15405
- By:
- Publication type:
- Article
A good manufacturing practice method to ex vivo expand natural killer cells for clinical use.
- Published in:
- Blood Transfusion (17232007), 2015, v. 13, n. 3, p. 464, doi. 10.2450/2015.0231-14
- By:
- Publication type:
- Article
ROR1 is an accurate and reliable marker of minimal residual disease in chronic lymphocytic leukaemia.
- Published in:
- British Journal of Haematology, 2020, v. 190, n. 6, p. e346, doi. 10.1111/bjh.16910
- By:
- Publication type:
- Article
Redefining the prognostic likelihood of chronic lymphocytic leukaemia patients with borderline percentage of immunoglobulin variable heavy chain region mutations.
- Published in:
- British Journal of Haematology, 2020, v. 189, n. 5, p. 853, doi. 10.1111/bjh.16434
- By:
- Publication type:
- Article
Biallelic BIRC3 inactivation in chronic lymphocytic leukaemia patients with 11q deletion identifies a subgroup with very aggressive disease.
- Published in:
- British Journal of Haematology, 2019, v. 185, n. 1, p. 156, doi. 10.1111/bjh.15405
- By:
- Publication type:
- Article
Unravelling the suboptimal response of TP53‐mutated chronic lymphocytic leukaemia to ibrutinib.
- Published in:
- British Journal of Haematology, 2019, v. 184, n. 3, p. 392, doi. 10.1111/bjh.15613
- By:
- Publication type:
- Article
Immunophenotypic and functional characterization of ex vivo expanded natural killer cells for clinical use in acute lymphoblastic leukemia patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 2, p. 201, doi. 10.1007/s00262-014-1614-z
- By:
- Publication type:
- Article
Immunomodulatory Effects of IFNα on T and NK Cells in Chronic Myeloid Leukemia Patients in Deep Molecular Response Preparing for Treatment Discontinuation.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 19, p. 5594, doi. 10.3390/jcm11195594
- By:
- Publication type:
- Article
TH2/TH1 Shift Under Ibrutinib Treatment in Chronic Lymphocytic Leukemia.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.637186
- By:
- Publication type:
- Article